Advisor Group, Inc. - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 62 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2018$053
+8.2%
0.00%
Q3 2018$0490.0%0.00%
Q2 2018$0490.0%0.00%
Q1 2018$049
-3.9%
0.00%
Q4 2017$0
-100.0%
51
-93.2%
0.00%
Q3 2017$2,0000.0%749
-5.1%
0.00%
Q2 2017$2,000789
+1510.2%
0.00%
Q1 2017$049
-45.6%
0.00%
Q4 2016$090
+83.7%
0.00%
Q3 2016$049
-55.5%
0.00%
Q2 2016$01100.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 5,292,156$7,144,0000.82%
Northeast Financial Consultants Inc 732,265$988,0000.30%
Family Management Corp 10,424$14,0000.01%
LMR Partners LLP 81,550$110,0000.01%
ELEMENT CAPITAL MANAGEMENT LLC 148,528$201,0000.01%
Poehling Capital Management, INC. 3,302$4,0000.00%
Paloma Partners Management Co 143,800$194,0000.00%
Founders Capital Management 3,000$4,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 186,254$251,0000.00%
FNY Investment Advisers, LLC 4,230$5,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders